ERG is found in malignant and benign vascular endothelial tumors, including hemangiomas and Kaposi sarcoma. It is also present in various prostate carcinomas, but absent in breast, colon and urothelium carcinomas. SensiStainTM Anti-Recombinant ERG Antibody is useful for differentiating prostate carcinoma from non-prostatic epithelial tumors, and for recognizing vascular endothelial neoplasms.
Formulation
Tris Buffer, pH 7.3 - 7.7, with 1% BSA and <0.1% Sodium Azide
Immunogen
Recombinant Protein
Immunogen Region
Recombinant Protein
Isotype
IgG
Raised In
Rabbit
Shipping Condition
Ice packs
Species Reactivity
Human
Specificity
ERG
Note
1:50-1:200
Clone No
IHC569
Purity
Purified
Storage
This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt.